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Abstract 24 
The PA-X protein of influenza A virus was recently found to have arisen from 25 
ribosomal frame-shift during PA translation. The X ORFs of PA-X of diverse 26 
influenza A viruses can be divided into two groups according to the protein length: 27 
full length PA-X (61 amino acids) and truncated PA-X (41 amino acids). A previous 28 
study reported that the truncation of PA-X may be associated with the adaptation and 29 
emergence of the influenza virus in host species. However, the role of the C-terminal 30 
20 amino acids of PA-X in influenza A viruses is still unclear. In the present study, a 31 
variety of epidemiologically important influenza A virus strains, including 2009 32 
pandemic H1N1 (pH1N1), a highly pathogenic avian influenza virus of the H5N1 33 
subtype, and a lowly pathogenic avian H9N2 influenza virus, served as models of 34 
prevalent human and avian influenza viruses, respectively, to evaluate the impact of 35 
the C-terminal 20 amino acids of PA-X on viral replication and pathogenicity. For all 36 
tested viruses, those with full-length PA-X replicated more efficiently and caused 37 
more apoptosis in human lung cells than truncated ones. Viruses with full length PA-X 38 
were also more virulent and caused more severe inflammatory responses in mice than 39 
those with truncated PA-X. The C-terminal 20 amino acids of full-length PA-X 40 
accelerated nuclear accumulation of PA protein and enhanced polymerase activity of 41 
pH1N1, H5N1, and H9N2 viruses. The current study addresses the role of the 42 
C-terminal 20 amino acids of full length PA-X on the biological characteristics of 43 
influenza A viruses. 44 
45 
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Importance 46 
In nature, the PA-X proteins of many types of influenza A viruses can be divided 47 
into two groups according to the protein length: those with full-length PA-X and those 48 
with truncated PA-X. The role of the C-terminal 20 amino acids of PA-X in current 49 
epidemiologically important influenza A virus strains, including 2009 pandemic 50 
H1N1 (pH1N1), highly pathogenic avian influenza H5N1 and a lowly pathogenic 51 
avian H9N2 influenza viruses was demonstrated. Possible underlying processes 52 
including cell death, polymerase activity, and changes in PA protein function were 53 
also evaluated. The current findings suggest that the C-terminal 20 amino acids of 54 
PA-X enhanced replication and pathogenicity in A549 cells and mice for pH1N1, 55 
H5N1, and H9N2 viruses, which were associated with increased RNP polymerase 56 
activity, apoptosis, and elevated inflammatory response. The current study assesses 57 
the C-terminal 20 amino acids of PA-X as a virulence factor in the moderation of viral 58 
pathogenesis and pathogenicity.59 
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Introduction 60 
Influenza A virus (IAV) poses a significant threat to public health and causes 61 
considerable economic losses to the livestock industry. The magnitude of 62 
pathogenicity depends on virus and host. Infections range from asymptomatic to 63 
100% lethal. The reasons for this disparity in pathogenesis are unclear because the 64 
molecular signatures of virulence of influenza viruses are not known. IAV is an 65 
enveloped negative-strand RNA virus, and its genome comprises eight viral RNA 66 
(vRNA) segments. The genome of the influenza virus may encode 10 viral proteins in 67 
total, PB2, PB1, PA, HA, NP, NA, M1, M2, NS1, and NS2 (1, 2). Additional novel 68 
proteins have been discovered as a second or third polypeptide made from PB1 and 69 
PA mRNA. Some of these proteins, such as PB1-F2 and PA-N155, are virulence 70 
factors for the influenza virus (3-5). Recently, it has been demonstrated that segment 3 71 
of the influenza A virus encodes not only the PA protein but also an additional novel 72 
protein, PA-X, translated as a +1 frameshift open reading frame (X-ORF) extension of 73 
a growing PA polypeptide (6). PA-X inhibits host protein synthesis and hinders the 74 
host antiviral response (6, 7). Interestingly, PA-X in the 1918 pandemic H1N1 virus 75 
reduces viral pathogenicity in mice (6). 76 
PA-X is a fusion protein that comprises the N-terminal domain of PA (191 amino 77 
acids) and the C-terminal domain X. Comprehensive genetic analysis showed that the 78 
X ORFs of diverse influenza A viruses can be divided into two groups according to 79 
the protein length (8). Avian, equine, and human seasonal H3N2 and H1N1 influenza 80 
viruses express a full-length PA-X protein with 61 amino acids in the X domain. By 81 
contrast, some influenza A viruses, including human 2009 pandemic H1N1 (pH1N1), 82 
canine, and certain swine influenza viruses possess a TGG (Trp) to TAG (stop codon) 83 
mutation at codon 42 in the X-ORF. This mutation produces a truncated PA-X protein 84 
with 41 amino acids in the X domain. It remains unclear whether the C-terminal 20 85 
amino acids of PA-X influence the biological characteristics of the virus. 86 
pH1N1 influenza virus infection was the first pandemic of the 21st century and is 87 
still circulating in human and pig populations (9-11). The highly pathogenic H5N1 88 
avian influenza viruses have undergone widespread geographic expansion among wild 89 
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and domestic birds. They are deadly pathogens in chickens and humans and may 90 
cause a future influenza pandemic (12-14). H9N2 influenza viruses are endemic in 91 
many terrestrial avian species in Asia and occasionally transmit to mammalian species 92 
including humans and pigs (15-19). The PA-X ORFs of pH1N1viruses are the 93 
truncated 41 amino acids in the X domain, and H5N1 and H9N2 avian influenza 94 
viruses express full-length PA-X with 61 amino acids in the X domain (Fig. 1A). To 95 
understand the role of the C-terminal 20 amino acids in the of PA-X in these influenza 96 
viruses, the effects of the full length and truncated forms of pH1N1, H5N1, and H9N2 97 
PA-X on polymerase activity, viral replication, and pathogenicity were evaluated in 98 
mammalian cells and mice. Viruses with full-length PA-X here showed higher 99 
polymerase activity, replication, and pathogenicity than viruses with truncated PA-X 100 
in the indicated three strains.  101 
Results 102 
Generation of full-length PA-X pH1N1 and truncated PA-X H5N1 and H9N2 103 
viruses 104 
To assess the function of the C-terminal 20 amino acids of PA-X, sets of 105 
A/Beijing/16/2009 (BJ/09, pH1N1), A/Anhui/1/2005 (AH/05, H5N1) and 106 
A/chicken/Hebei/LC/2008 (HB/08, H9N2) viruses (full-length and truncated PA-X) 107 
were generated using reverse genetics. A698G of PA-X ORF in pH1N1-61X and 108 
G698A of PA-X ORF in H5N1-41X and H9N2-41X viruses did not affect the PA ORF 109 
(Fig. 1A). Western blotting was performed to demonstrate the PA-X expression in all 110 
indicated viruses infected MDCK cells (Fig. 1B). PA-X was detected in pH1N1-41X 111 
(WT), pH1N1-61X, H5N1-61X (WT), H5N1-41X, H9N2-61X (WT), and H9N2-41X 112 
infected cells. 113 
The C-terminal 20 amino acids of full-length PA-X played a role in viral 114 
replication and apoptosis of influenza viruses in human lung cells 115 
Six viruses were used to infect MDCK and A549 cells at an MOI of 0.01, and the 116 
supernatants were collected and titrated at 12, 24, 36, 48, 60, 72, 84, and 96 hpi. There 117 
was no significant difference in viral output from MDCK cells between two forms of 118 
pH1N1, H5N1, and H9N2 viruses (Fig. 2A). However, with A549 cells, the mutant 119 
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virus with full-length PA-X, pH1N1-61X, showed higher levels than those with 120 
truncated PA-X [pH1N1-41X (WT)] from 48 hpi (P < 0.05) (Fig. 2B). H5N1-61X 121 
(WT) with full length PA-X showed higher replication levels than H5N1-41X with 122 
truncated PA-X at 84 and 96 hpi (P < 0.05). Full length PA-X virus, H9N2-61X (WT), 123 
produced higher virus levels than with truncated PA-X, H9N2-41X, at 24, 36, and 48 124 
hpi (P < 0.05). The data from A549 cells showed that pH1N1, H5N1, and H9N2 125 
viruses with full length PA-X appeared to replicate more efficiently than 126 
corresponding viruses with truncated PA-X. 127 
Influenza viruses induce apoptosis and necrosis in infected cells, so causing cellular 128 
and organ damage (20, 21). It has been previously shown that several viral proteins 129 
(NA, M1, NS1, and PB1-F2) promote apoptosis in cells (22-26). To evaluate the 130 
effect of the C-terminal 20 amino acids of full length PA-X on cell death, A549 cells 131 
were infected with a panel of recombinant viruses at 1.0 MOI for 12 h. Evaluation of 132 
apoptosis and necrosis by flow cytometry for annexinV+ and PI+ cells revealed that 133 
pH1N1-61X virus caused more apoptosis (22.94%) than pH1N1-41X (WT) virus 134 
(13.25%) (P < 0.05) (Fig. 2C). Similarly, H5N1-61X (WT) virus produced more 135 
apoptotic cells (27.5%) than H5N1-41X virus (17.97%) and H9N2-41X virus 136 
produced fewer apoptotic cells (11.82%) than H9N2-61X (WT) virus (15.17%) (P < 137 
0.05). These results indicated that viruses with full length PA-X induced an increase in 138 
apoptosis in A549 cells than those with truncated PA-X for pH1N1, H5N1 and H9N2 139 
viruses. 140 
Viruses with full-length PA-X were more virulent than those with truncated 141 
PA-X in mice 142 
To assess the pathogenicity of PA-X mutants, six-week-old BALB/c mice were 143 
intranasally inoculated with each virus. Clinical signs, mortality, and weight loss were 144 
monitored over 14 days. Virus-infected mice were humanely killed at 3, 5, and 7 days 145 
post-infection (dpi), and lungs were collected for virus titration. For pH1N1 mutants, 146 
survival curves for the 105 TCID50 infection dose clearly showed that pH1N1-61X 147 
had a higher pathogenicity than pH1N1-41X (WT). pH1N1-61X had 100% mortality 148 
by 8 dpi; pH1N1-41X (WT) caused no deaths (Fig. 3A). The loss of body weight due 149 
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to pH1N1-61X was greater than that attributed to pH1N1-41X (WT) (Fig. 3B). The 150 
pathogenicity of these viruses was further demonstrated by histopathology of lung 151 
tissues collected at 5 dpi. As shown in Fig. 5A, pH1N1-61X caused more severe 152 
lesions than pH1N1-41X (WT) mutants, exhibiting extensive alveolar damage and 153 
cellular infiltration. Moderate interstitial pneumonia was observed in pH1N1-41X 154 
(WT)-infected lungs. pH1N1-61X showed higher viral replication in the lung than 155 
pH1N1-41X (WT) at 5 and 7 dpi (Fig. 4B).  156 
In H5N1 mutants, H5N1-41X (MLD50 = 102.75 TCID50) was attenuated in mice than 157 
H5N1-61X (WT) of which MLD50 was 102.25 TCID50, and body weight loss of 158 
H5N1-41X-infected mice were less than H5N1-61X (WT) after inoculation at 102 159 
TCID50 or 103 TCID50 (Fig. 3D & F). The survival curves showed that H5N1-61X 160 
(WT) was more pathogenic than H5N1-41X. H5N1-61X had 100% mortality by 9 dpi; 161 
H5N1-41X caused 66.6% mortality after inoculation at 103 TCID50. H5N1-61X (WT) 162 
showed greater pathogenicity than H5N1-41X, with 33.3% mortality by 12 dpi; 163 
H5N1-41X caused no deaths after inoculation at 102 TCID50 (Fig. 3C & E). The titers 164 
of H5N1-41X in lungs were signiﬁcantly lower than those of H5N1-61X (WT) at 3 165 
and 7 dpi (P < 0.05) in mice that had been inoculated with 103 TCID50 of each H5N1 166 
mutant (Fig. 4C). Both H5N1-61X (WT) and H5N1-41X were detected in the brains 167 
and blood of mice, but H5N1-61X (WT) showed a higher replication level in the brain 168 
than H5N1-41X at 5 dpi (Fig. 5D). Mice infected with H5N1-61X (WT) showed more 169 
severe lesions than those infected with H5N1-41X. These infections were 170 
characterized by interstitial edema, thickening of the alveolar walls, and cellular 171 
infiltration (Fig. 4A). 172 
As indicated in the survival curves of mice infected with H9N2 mutants at 106 173 
TCID50, H9N2-41X infection resulted in no deaths, but H9N2-61X (WT) infection 174 
had 33.3% mortality (Fig. 3G). The maximum weight loss from H9N2-61X (WT) and 175 
H9N2-41X infection was 12% and 5%, respectively (Fig. 3H). Lungs infected with 176 
H9N2-41X virus appeared almost normal, but mild pathological changes were 177 
detected in the H9N2-61X (WT) group. Some vessel walls were surrounded by 178 
inflammatory cells and epithelial erosion of bronchial lining (Fig. 4A). The viral titers 179 
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of lungs infected with H9N2-41X were lower than those of those infected with 180 
H9N2-61X (WT) at 3, 5, and 7 dpi (P < 0.05) (Fig. 4E). This was consistent with the 181 
observed pathology.  182 
Collectively, these results indicated that pH1N1, H5N1, and H9N2 viruses with 183 
full-length PA-X were more pathogenic than those with truncated PA-X.  184 
Viruses with full-length PA-X caused more severe inflammatory responses in 185 
mice than those with truncated PA-X 186 
Severe influenza virus infection in human and animal models is associated with 187 
abnormally elevated pulmonary pro-inflammatory cytokine and chemokine expression 188 
(27-30). To assess the effect of the C-terminal 20 amino acids of PA-X on host 189 
inflammatory response, the protein levels of seven cytokines and chemokines in the 190 
lungs of infected mice were measured at 3 and 5 dpi. 191 
 Mice infected with pH1N1-61X containing full-length PA-X virus exhibited 192 
higher titers of IFN-γ, IL-1β, IL-6, KC, TNF-α, and MIP-1α than those with 193 
pH1N1-41X (WT) at 3 and 5 dpi (P < 0.05) (Fig. 5A). Mice infected with H5N1-61X 194 
with full-length PA-X showed higher levels of IFN-γ, IL-6, KC, TNF-α, and MIP-1α 195 
than H5N1-41X expressing truncated PA-X at 3 or 5 dpi (P < 0.05) (Fig. 5B). For 196 
H9N2 mutants, all the chemokine and cytokine levels of H9N2-61X (WT) were 197 
higher than that of H9N2-41X at 3 and 5 dpi (P < 0.05) (Fig. 5C). 198 
These results showed that infection with pH1N1, H5N1, and H9N2 viruses carrying 199 
full-length PA-X tended to elicit a more severe inflammatory response than infection 200 
with truncated PA-X viruses.  201 
Full-length PA-X proteins exhibited higher polymerase activity than their 202 
respective truncated forms 203 
The viral ribonucleoprotein (RNP) complex has been shown to be correlated with 204 
viral replication and pathogenicity (31, 32). An influenza virus mini-genome assay 205 
was performed on 293T cells to determine the effect of the C-terminal 20 amino acids 206 
of PA-X on viral polymerase activity (33). The RNP polymerase activity from 207 
pH1N1-61X expressing full length PA-X protein was 50% more pronounced than that 208 
of pH1N1-41X (WT) (P < 0.05) (Fig. 6A). H5N1-41X showed 15% less RNP 209 
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polymerase activity than H5N1-61X (WT) (P < 0.05) (Fig. 6B). For the H9N2 virus 210 
constructs, H9N2-61X (WT) RNP activity was 25% greater than that of H9N2-41X (P 211 
< 0.05) (Fig. 6C). These results indicated full-length PA-X proteins had more 212 
polymerase activity than their respective truncated forms of PA-X in the pH1N1, 213 
H5N1, and H9N2 viruses.  214 
Protein lysates derived from 293T cells transfected with RNP plasmids were 215 
analyzed by Western blotting. Synonymous mutations in PA genes did not affect PA 216 
protein expression for pH1N1, H5N1, or H9N2 viruses (Fig. 6D). In summary, the 217 
more pronounced RNP polymerase activity of full-length PA-X in pH1N1, H5N1, and 218 
H9N2 viruses was found not to be due to the differences in expression of the PA 219 
protein. 220 
The C-terminal 20 amino acids of full length PA-X increased the nuclear 221 
localization of PA protein and suppressed non-viral protein expression 222 
Accumulation of PA protein in the nucleus was found to be correlated with the 223 
pathogenicity of influenza viruses in mice (34-36). The role of the C-terminal 20 224 
amino acids of PA-X on PA protein accumulation in the nuclei of infected cells was 225 
evaluated. A549 cells were infected with full-length and truncated PA-X pH1N1, 226 
H5N1, and H9N2 viruses at 2.0 MOI. The extension of cytoplasmic accumulation of 227 
PA into the nucleus was accelerated such that, at 6 hpi, more cells were infected with 228 
pH1N1 or H5N1 virus with full length PA-X than with truncated. At 10 hpi, more 229 
cells infected with H9N2 virus with full-length PA-X showed nuclear presence of PA 230 
than cells infected with the corresponding virus with truncated PA-X (Fig. 7). 231 
The PA gene plays a major role in the suppression of host protein synthesis, and this 232 
role involves PA-X (6, 37). In order to determine the role of the C-terminal 20 amino 233 
acids of PA-X in the suppression of host protein synthesis, the PA activity of 234 
full-length PA-X was compared to that of truncated PA-X in pH1N1, H5N1, and 235 
H9N2 viruses. Specifically the suppression of non-viral protein synthesis was 236 
observed in 293T cells over the course of 24 h using co-transfection of pEGFP and 237 
corresponding PA plasmids. There was significantly less eGFP expression in the 238 
presence of H1N1-61X than in the presence of H1N1-41X (WT), and there was 239 
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significantly more in the presence of H5N1-41X PA and H9N2-41X PA than in the 240 
presence of H5N1-61X (WT) PA or H9N2-61X (WT) PA respectively (Fig. 8). In this 241 
way, full-length PA-X was found to speed up nuclear accumulation of PA protein and 242 
render PA more effective in suppressing non-viral protein expression. 243 
Discussion 244 
The polymerase activity, viral replication, and pathogenicity of the full length and 245 
truncated forms of PA-X were evaluated in pH1N1, H5N1, and H9N2 viruses. In all 246 
three strains viruses with full length PA-X showed more polymerase activity, 247 
replication, and pathogenicity than those with truncated PA-X. 248 
Two forms of PA-X proteins were observed in influenza A viruses: the full-length 249 
form (61 amino acids in X-ORF) and the truncated form (41 amino acids in X-ORF) 250 
(6, 8). The two forms of PA-X in pH1N1, H5N1, and H9N2 viruses showed no 251 
significant difference in virus replication in MDCK cells. Jagger et al. reported 252 
similar results in MDCK cells but found no difference in single or multicycle growth 253 
kinetics of the 1918 H1N1 PA-X-deficient virus and wild type (6). However, it was 254 
here found that pH1N1, H5N1, and H9N2 viruses with full-length PA-X showed 255 
higher replication levels and caused more apoptosis in A549 cells than those with 256 
truncated PA-X. Results also showed that full-length PA-X exhibited more 257 
pathogenicity (mortality and lung pathology) than truncated PA-X in corresponding 258 
viruses. These results suggest that the mutational switch from truncated to full-length 259 
PA-X could indicate increased pathogenicity. Attention should be paid to the switch 260 
from truncated PA-X to the full-length form. Although 2009 pandemic H1N1 virus 261 
strains with full-length PA-X do not appear in nature at present, the possibility of 262 
pH1N1 acquiring full-length PA-X proteins by mutation cannot be excluded. 263 
Results showed that pH1N1, H5N1, and H9N2 viruses with full-length PA-X had 264 
more polymerase activity than those with truncated PA-X. This was consistent with 265 
their pathogenicity. The full-length and truncated PA-X differed in the presence of 20 266 
amino acids near the C-terminal. It is here suggested that the C-terminal 20 amino 267 
acids of the full length PA-X contribute to viral polymerase activity and pathogenicity. 268 
There is some evidence that pathogenicity is associated with inflammatory 269 
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responses. Cytokine and chemokine responses, including those of IL-1β, IFN-γ, TNF- 270 
α, MIP-1α, IL-6, MIP-2, MCP-1, KC, and IL-1α, were found to be associated with the 271 
recruitment of macrophages and neutrophils to the infected lungs, which caused acute 272 
lung inflammation (30). Jagger et al. found that PA-X down-regulated the immune 273 
response and inflammation during infection with the 1918 pandemic virus (6). In the 274 
current study, in pH1N1, H5N1, and H9N2 viruses, full-length PA-X tended to elicit 275 
more severe pro-inflammatory responses and more pathogenicity than truncated PA-X. 276 
It is here suggested that full length PA-X could promote host inflammatory response.  277 
The C-terminal 20 amino acids of full-length PA-X affected nuclear accumulation 278 
of PA protein and support the suppressive role of PA protein on host protein synthesis. 279 
Previous studies have reported that the level of polymerase accumulation in the nuclei 280 
of infected cells is correlated with the virulence of influenza virus (34, 38). The 281 
present study showed that the C-terminal 20 amino acids of full-length PA-X 282 
accelerated nuclear accumulation of the PA protein in A549 cells. The increased 283 
nuclear accumulation of PA was consistent with the increased virulence of pH1N1, 284 
H5N1, and H9N2 viruses. In addition, PA proteins with full-length PA-X were more 285 
effective in suppressing host protein expression, suggesting that the C-terminal 20 286 
amino acids of full-length PA-X play a role in the suppression of host protein 287 
synthesis. 288 
Under natural conditions, there are changes in the length of PA-X protein of 289 
influenza A viruses. For example, truncation of PA-X occurs when avian and equine 290 
influenza viruses are introduced to canines, and the classic swine H1N1 viruses with 291 
the truncated form of PA-X (a cluster of viruses sampled between 1985 and 2009) 292 
were directly derived from those with full-length PA-X (a group of generally older 293 
1930 to 2006 classic swine H1N1 viruses) (8). For these reasons, epidemiological 294 
surveys should pay attention to viruses full-length PA-X, especially pH1N1 viruses. 295 
Materials and methods 296 
Ethics statement 297 
All animal work was approved by the Beijing Association for Science and 298 
Technology (approval ID SYXK [Beijing] 2007-0023) and conducted in strict 299 
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accordance with the Beijing Laboratory Animal Welfare and Ethics guidelines, as 300 
issued by the Beijing Administration Committee of Laboratory Animals, and in 301 
accordance with the China Agricultural University (CAU) Institutional Animal Care 302 
and Use Committee guidelines approved by the Animal Welfare Committee of CAU.  303 
Viruses and cells 304 
A/Beijing/16/2009 (BJ/09, pH1N1), A/Anhui/1/2005 (AH/05, H5N1), and 305 
A/chicken/Hebei/LC/2008 (HB/08, H9N2) viruses were described previously (39, 40). 306 
Human embryonic kidney cells (293T), Madin-Darby canine kidney cells (MDCK), 307 
and human pulmonary adenocarcinoma cells (A549) were maintained in Dulbecco’s 308 
modified Eagle’s medium (DMEM; Life Technologies, Foster City, CA, U.S.) 309 
supplemented with 10% fetal bovine serum (FBS; Life Technologies), 100 units/ml of 310 
penicillin and 100 g/ml of streptomycin.  311 
Generation of recombinant viruses by reverse genetics 312 
All eight gene segments were amplified by reverse transcription-PCR (RT-PCR) 313 
from BJ/09, AH/05, and HB/08 viruses and cloned into the dual-promoter plasmid, 314 
pHW2000. The mutations were introduced into the PA gene using a Site-directed 315 
QuikChange Mutagenesis Kit according to the manufacturer’s instructions (Agilent, 316 
Santa Clara, CA, U.S.). PCR primer sequences are available upon request. pH1N1 317 
with full-length PA-X (61 amino acids), pH1N1-61X, had a stop (UAG)-to-tryptophan 318 
codon (UGG) substitution at position 42 in X ORF (stop42W) without changing the 319 
PA ORF (Fig. 1B). H5N1 and H9N2 viruses with truncated PA-X (41 amino acids), 320 
H5N1-41X and H9N2-41X, which had a tryptophan (UGG)-to-stop codon (UAG) 321 
substitution at 42 site in X ORF (W42stop) without altering the PA ORF. Rescued 322 
viruses were detected using hemagglutination assays. Viral RNA was extracted and 323 
analyzed by RT-PCR, and each viral segment was sequenced to confirm sequence 324 
identity.  325 
All experiments with live viruses and transfectants generated by reverse genetics 326 
were performed in a biosafety level 3 containment laboratory approved by the 327 
Ministry of Agriculture of the People’s Republic of China. 328 
Viral titration and replication kinetics  329 
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The 50% tissue culture infectious dose (TCID50) was determined in MDCK cells 330 
using 10-fold serially diluted virus inoculated at 37°C and cultured for 72 h. The 331 
TCID50 values were calculated using the method first described by Reed and Muench 332 
(41). 333 
MDCK and A549 cells were infected with virus at a multiplicity of infection 334 
(MOI) of 0.01. Supernatants of the infected MDCK cells were harvested at 6, 12, 24, 335 
36, 48, 60, 72, and 84 h post infection (hpi). Supernatants of the infected A549 cells 336 
were harvested at 12, 24, 36, 48, 60, 72, 84, and 96 hpi. Viral titers were determined 337 
in MDCK cells from the TCID50. Three independent experiments were performed. 338 
Mouse infection 339 
Fifteen mice (six week-old female BALB/c; Vital River Laboratory, Beijing, China) 340 
per group were anesthetized with Zoletil (tiletamine-zolazepam; Virbac S.A., Carros, 341 
France; 20 µg/g) and inoculated intranasally with 50 μl of 105 TCID50 of pH1N1 or 342 
102 or 103 TCID50 of H5N1 or 106 TCID50 of H9N2, diluted in phosphate-buffered 343 
saline (PBS). All mice were monitored daily for 14 days; mice that lost 30% of their 344 
original body weight were humanely euthanized. Three mice were euthanized 3, 5, 345 
and 7 days post infection (dpi) for determination of lung virus titers, histology, and 346 
cytokine levels. Lungs were collected and homogenized in 1 ml of cold PBS. Virus 347 
titers were determined by TCID50. The 50% minimum lethal dose (MLD50) values 348 
were determined by intranasally inoculating groups of three mice with 10-fold 349 
dilutions of virus and were calculated by the method of Reed and Muench (41). 350 
Histopathology 351 
At 5 dpi, a portion of lung from each euthanized mouse was fixed in 10% 352 
phosphate-buffered formalin and processed for paraffin embedding. Each 5 μm 353 
section was stained with hematoxylin and eosin (H&E) and examined for 354 
histopathological changes. Images were captured with a Zeiss Axioplan 2IE 355 
epifluorescence microscope. 356 
Polymerase activity assays 357 
RNP Minigenome Luciferase Assay. Four expression plasmids housing PB2, PB1, 358 
PA, and NP (125 ng each) from BJ/09, AH/05 and HB08 viruses [pH1N1-41X (WT), 359 
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pH1N1-61X, H5N1-61X (WT), H5N1-41X, H9N2-61X (WT), and H9N2-41X)] were 360 
cloned based on the eukaryotic expression vector pcDNA3.1 and co-transfected into 361 
293T cells with fire-fly luciferase reporter plasmid pYH-NS1-Luci (10 ng) and 362 
internal control plasmid expressing renilla luciferase (2.5 ng). The assay was 363 
performed at 37°C. At 24 hpi, cell lysate was prepared using a Dual-Luciferase 364 
Reporter Assay System (Promega) and luciferase activity was measured using a 365 
GloMax 96 microplate luminometer (Promega). 366 
Quantification of cytokine and chemokine protein levels in mouse lungs  367 
Levels of cytokines and chemokines, including interleukin-1 beta (IL-1β), 368 
interleukin-6 (IL-6), mouse interleukin-8 (IL-8), monocyte chemotactic protein 1 369 
(MCP-1), macrophage inflammatory protein 1 alpha (MIP-1α), tumor necrosis factor 370 
alpha (TNF-α), and interferon γ (IFN-γ) in the lung were determined using a 371 
cytometric bead array method (BD Cytometric BEAD Array Mouse Inflammation Kit; 372 
BD Bioscience, San Diego, CA, U.S.). Briefly, 50 µl mouse inflammation capture 373 
bead suspension and 50 µl detection reagent were added to an equal amount of sample 374 
and incubated in the dark for 2 h at room temperature. Samples were later washed 375 
with 1 ml wash buffer and then centrifuged at 200 × g at room temperature for 5 min. 376 
Supernatants were discarded and 300 µl wash buffer was added. Samples were 377 
analyzed on a BD FACS Array bioanalyzer (BD Bioscience). Data were analyzed 378 
using BD CBA Software (BD Bioscience). Chemokine and cytokine levels were 379 
recorded as pg/ml in the homogenate. 380 
Cell death assays 381 
Virus infection assays were conducted in 6-well plates. Cells were seeded at a 382 
density of 1×106 cells/well for overnight in infection media (cell growth media with 383 
1% bovine serum albumin (BSA) was used in place of FCS). Cells were then infected 384 
with virus at 1.0 MOI for 12 h. Cells from the supernatant and monolayers were then 385 
harvested, washed, and stained with APC labeled annexin and propidium iodide (PI) 386 
(Becton Dickinson, San Jose, CA, U.S.) for 20 min. After a final wash step, cells were 387 
resuspended in 100 μl FACs wash buffer (PBS containing 3% BSA and 0.01% sodium 388 
azide) and analyzed on the FACs Calibur (BD Biosciences) and BD CellQuest Pro 389 
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software (version 5.2.1, BD Biosciences). Cell death (apoptosis and necrosis) was 390 
defined as annexin-V+ and PI+, while apoptotic cells were annexin-V+ only. Viable 391 
cells were considered neither annexin-V nor PI positive. 392 
Western blotting 393 
Total cell protein lysates were extracted from transfected 293T cells and infected 394 
MDCK cells with CA630 lysis buffer (150 mM NaCl, 1% CA630 detergent, 50 mM 395 
Tris base [pH 8.0]). Cellular proteins were separated by 12% sodium dodecyl 396 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a 397 
polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences, Freiburg, 398 
Germany). Each PVDF membrane was blocked with 0.1% Tween 20 and 5% nonfat 399 
dry milk in Tris-buffered saline and subsequently incubated with a primary antibody. 400 
Primary antibodies were specific to influenza A virus PA (1:3000, GeneTex, Alton 401 
Pkwy Irvine, U.S.), influenza A virus NP (diluted 1:3000, GeneTex U.S.), influenza A 402 
virus PA-X (diluted 1:2000, was provided by Dr. Xiufan Liu of YangZhou University, 403 
China). Secondary antibodies used here included horse radish peroxidase 404 
(HRP)-conjugated anti-mouse antibody or HRP-conjugated anti-rabbit antibody 405 
(diluted 1:10,000 Jackson ImmunoResearch, West Grove, U.S.), as appropriate. HRP 406 
presence was detected using a Western Lightning Chemiluminescence Kit in 407 
accordance with the manufacturer’s protocol (Amersham Pharmacia, Freiburg, 408 
Germany).  409 
Immunofluorescence 410 
A549 cells were grown on glass-bottom dishes and infected at 2.0 MOI with the 411 
indicated virus. At specified points in time after infection, the cells were fixed with 412 
PBS containing 4% paraformaldehyde for 20 min and permeabilized with PBS 413 
containing 0.5% Triton X-100 for 30 min. After blocking with 5% BSA in PBS, the 414 
cells were incubated with rabbit antisera against PA (diluted 1:400 GeneTex U.S.) at 415 
room temperature for 2 h. The cells were then washed three times with PBS and 416 
incubated for 1 h with fluorescein isothiocyanate (FITC)-coupled goat anti-rabbit 417 
secondary antibodies (diluted 1:100, Jackson ImmunoResearch, U.S.). The cells were 418 
subsequently washed three times with PBS and incubated with 4′, 419 
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6-diamidino-2-phenylindole (DAPI) for 10 min. Cells were imaged with a laser 420 
scanning confocal microscope (Leica). Localization of PA protein in the nucleus was 421 
determined by counting infected cells with nuclear presence of PA (n=100). The 422 
results shown represent three independent experiments. 423 
Statistical analysis 424 
The statistical analyses were performed using GraphPad Prism Software Version 425 
5.00 (GraphPad Software Inc., San Diego, CA, U.S.). Comparison between two forms 426 
of treatment involved two-tailed Student’s t-test; multiple comparisons were carried 427 
out using two-way analysis of variance (ANOVA) considering time and virus as 428 
factors. Differences were considered statistically significant at P < 0.05. The data are 429 
reported as the mean ± standard deviation (SD).  430 
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Figure legends 580 
 581 
Figure 1. PA-X and PA sequences of viruses used in this study. (A) Sequences of 582 
the C-terminal regions of PA-X proteins of several epidemiologically important 583 
strains. (B) Western blot analysis for the detection of PA-X protein in MDCK cells 584 
infected with pH1N1, H5N1, and H9N2 mutant viruses. 585 
586 
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587 
 588 
Figure 2. pH1N1, H5N1, and H9N2 viruses with full-length PA-X showed more 589 
replication and apoptosis in A549 cells. (A) Viral growth curves of pH1N1, H5N1. 590 
and H9N2 mutant viruses in MDCK cells and A549 cells over 84 and 96 h. Each 591 
value represents the mean of three independent experiments performed in triplicate; 592 
error bars indicate standard deviations. (B) Relative induction of cell death as 593 
determined by the detection of annexin+ and PI+ A549 cells infected with the indicated 594 
panel of viruses at a 1.0 MOI for 12 h. Representative dual-labeled quadrants of 595 
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bivariant fluorescence dot plots show the relative induction of apoptosis (annexin+) 596 
and necrosis (PI+) in infected cells. Apoptotic cells that were positive for annexin V 597 
but not PI are shown in the right lower quadrant, and those positive for PI but not 598 
annexin V are shown in the left upper quadrant. Percentages shown are proportions of 599 
apoptotic cells. Mock, uninfected control cells. * indicates significant differences 600 
between pH1N1-61X and pH1N1-41X (WT), H5N1-41X and H5N1-61X (WT), and 601 
H9N2-41X and H9N2-61X (WT). 602 
603 
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 604 
Figure 3. Mortality and weight loss in mice intranasally inoculated with PA-X 605 
mutant viruses. The data show the survival (percentage) of mice infected with (A) 606 
pH1N1 PA-X, (C&E) H5N1 PA-X, and (G) H9N2 PA-X mutant viruses. The body 607 
weight of mice inoculated with (B) pH1N1 PA-X, (D&F) H5N1 PA-X, and (H) H9N2 608 
PA-X mutant viruses was presented as percentage of the weight on the day of 609 
inoculation (day 0). Any mouse that lost more than 30% of its body weight was 610 
euthanized. The means of each group are shown, and error bars are standard 611 
deviations (SDs).  612 
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 613 
 614 
Figure 4. (A) Histopathological changes and (B, C, D, E) viral titers in lungs of 615 
mice infected with pH1N1, H5N1, and H9N2 mutant viruses. Scale bars, 100 µm. 616 
The mean viral lung load ± SD was calculated by log10 TCID50 determination in 617 
MDCK cells. * indicates significant difference between pH1N1-61X and pH1N1-41X 618 
(WT), H5N1-61X (WT) and H5N1-41X, and H9N2-61X (WT) and H9N2-41X.  619 
620 
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 623 
Figure 5. Detection of cytokine and chemokine proteins in lungs of mice infected 624 
with (A) pH1N1, (B) H5N1, and (C) H9N2 PA-X mutant viruses. Mean 625 
cytokine/chemokine levels ± SD are shown. * indicates significant differences 626 
between viruses with full length PA-X and truncated PA-X. 627 
628 
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629 
Figure 6. Full-length PA-X showed considerable viral polymerase activity. (A) 630 
Polymerase activity of (A) pH1N1, (B) H5N1, and (C) and H9N2 viruses with 631 
full-length PA-X and truncated PA-X, expressed as mean activity ± SD relative to 632 
corresponding wild-type PA set at 100% from three independent experiments. (D) 633 
Western blot detections of PA, NP, and β-actin in protein lysates from 293T cells 634 
transfected with polymerase plasmids. * indicates significant differences between 635 
pH1N1-61X and pH1N1-41X (WT), H5N1-61X (WT) and H5N1-41X, and 636 
H9N2-61X (WT) and H9N2-41X.  637 
638 
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 639 
Figure 7. Nuclear transport of PA proteins with full-length and truncated PA-X 640 
in infected cells. (A) PA protein in A549 cells infected with pH1N1-61X, 641 
pH1N1-41X (WT), H5N1-61X (WT), H5N1-41X, H9N2-61X (WT), and H9N2-41X 642 
virus at 2.0 MOI was localized by immunofluorescence at 2, 6, and 10 hpi. Nuclei 643 
were stained with DAPI. (B) At 6 hpi and 10 dpi, nuclear PA quantification was based 644 
on proportion of infected cells (n=100) with clear nuclear presence of PA. Values 645 
shown are means of the results of three independent experiments ± SDs. *, P < 0.05 646 
relative to cells infected with corresponding wild-type viruses. 647 
648 
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649 
Figure 8. PAs were more effective in suppressing non-viral protein synthesis with 650 
full length PA-X than with truncated. (A) 293T cells were co-transfected with eGFP 651 
expression plasmid and PA plasmids with full-length or truncated PA-X from pH1N1, 652 
H5N1, and H9N2 viruses. (A) Fluorescence images indicative of eGFP expression at 653 
24 h after transfection were captured under identical exposure conditions. (B) PA 654 
protein was determined using Western blotting and anti-PA antibody. Anti-β-actin 655 
antibody was used as a loading control. Control was 293T cells co-transfected with 656 
eGFP expression plasmid and empty pcDNA3.1 vector. 657 
